Your browser doesn't support javascript.
loading
Psychological distress in corticosteroid-naive patients with systemic lupus erythematosus: A prospective cross-sectional study.
Nishimura, K; Omori, M; Katsumata, Y; Sato, E; Kawaguchi, Y; Harigai, M; Yamanaka, H; Ishigooka, J.
Afiliação
  • Nishimura K; Department of Psychiatry, Tokyo Women's Medical University School of Medicine, Tokyo, Japan nishimura.katsuji@twmu.ac.jp.
  • Omori M; Kanagawa Psychiatric Center, Yokohama, Japan.
  • Katsumata Y; Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.
  • Sato E; Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.
  • Kawaguchi Y; Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.
  • Harigai M; Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.
  • Yamanaka H; Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.
  • Ishigooka J; Department of Psychiatry, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Lupus ; 25(5): 463-71, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26527504
ABSTRACT

OBJECTIVE:

Psychological distress, such as depression and anxiety, has been intensively studied in patients with systemic lupus erythematosus (SLE). However, those studies have mostly included patients who were treated with corticosteroids, which might themselves induce mood disturbances. We investigated psychological distress in corticosteroid-naive patients with SLE who did not exhibit any overt neuropsychiatric manifestations.

METHODS:

Forty-three SLE in-patients with no current or past abnormal neuropsychiatric history participated in the study. Patients and 30 healthy control subjects with similar demographic and personality characteristics were administered a comprehensive battery of psychological/neuropsychological tests. The Profile of Mood States (POMS) was used to assess depression and anxiety. Results of clinical, laboratory, and neurological tests were compared with regard to their presence.

RESULTS:

Prevalence of depression was higher in patients (n = 11, 25.6%) than in controls (n = 2, 6.7%; p = 0.035), although prevalence of anxiety did not differ across groups (patients 34.9%, n = 15; controls 16.7%, n = 5; p = 0.147). Using multiple logistic regression analysis, we identified avoidance coping methods (OR, 1.3; 95% CI 1.030-1.644; p = 0.027) as an independent risk factor for depression.

CONCLUSION:

Our results indicate that depression presents more frequently in corticosteroid-naive patients with early-stage, active SLE than in the normal population, but anxiety does not. Depression may be related to psychological reactions to suffering from the disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ansiedade / Estresse Psicológico / Depressão / Lúpus Eritematoso Sistêmico Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Lupus Assunto da revista: REUMATOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ansiedade / Estresse Psicológico / Depressão / Lúpus Eritematoso Sistêmico Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Lupus Assunto da revista: REUMATOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão